US FDA approves Eton's liquid therapy for rare water-balance disorder

By Kamal Choudhury Feb 25 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Eton Pharmaceuticals' first-of-its-kind liquid therapy for a rare hormonal disorder, offering a more ...
Business Wire

Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1

“The approval of GAMMAGARD LIQUID ERC reinforces our commitment to supporting individualized treatment approaches for people with primary immunodeficiency, including a therapeutic option that has the ...
Morningstar

Just in Time for Valentine's Day, BoomRx Launches Oral Liquid Erectile-Dysfunction Therapy

New ED Formulation Puts Focus on Men's Sexual Health as Part of Overall Wellness TAMPA, Fla., Jan. 28, 2026 /PRNewswire/ -- BoomRx, the fastest-growing national pharmaceutical technology platform that ...
Seeking Alpha

Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content¹

GAMMAGARD LIQUID ERC [immune globulin infusion (human)] with Less Than or Equal to 2 µg/mL IgA in a 10% Solution is Approved for Intravenous or Subcutaneous Use in People Aged Two and Older with ...
Rutland Herald

Takeda Announces U.S. Availability of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1

Takeda (TSE:4502/NYSE:TAK) today announced the U.S. availability of GAMMAGARD LIQUID™ ERC [immune globulin infusion (human)] with less than or equal to 2 µg/mL IgA in a 10% solution, by prescription, ...